Aplidin in patients with advanced dedifferentiated liposarcomas: a French Sarcoma Group Single-Arm Phase II study - Annals of Oncology
Oxidation and inactivation of low molecular weight protein tyrosine phosphatase by the anticancer drug Aplidin - Taddei - 2006 - International Journal of Cancer - Wiley Online Library
Aplidin® induces JNK-dependent apoptosis in human breast cancer cells via alteration of glutathione homeostasis, Rac1 GTPase activation, and MKP-1 phosphatase downregulation | Cell Death & Differentiation
JPM | Free Full-Text | Plitidepsin: Mechanisms and Clinical Profile of a Promising Antiviral Agent against COVID-19 | HTML
Dehydrodidemnin B - an overview | ScienceDirect Topics
Aplidin, plitidepsin, as PM90001 | PharmaMar
AplidinTM Induces Apoptosis in Human Cancer Cells via Glutathione Depletion and Sustained Activation of the Epidermal Growth Factor Receptor, Src, JNK, and p38 MAPK* - Journal of Biological Chemistry
Molecules | Free Full-Text | Approaches to the Potential Therapy of COVID-19: A General Overview from the Medicinal Chemistry Perspective | HTML
Exploring the effect of aplidin on low molecular weight protein tyrosine phosphatase by molecular docking and molecular dynamic simulation study - ScienceDirect
PharmaMar discovers new data on the mechanism | EurekAlert!
Plitidepsin: design, development, and potential place in therapy | DDDT
Frontiers | Exploring the Diversity of the Marine Environment for New Anti-cancer Compounds | Marine Science
Plitidepsin: design, development, and potential place in therapy | DDDT
Effect of Aplidin on MM cells stimulated with proliferative cytokines... | Download Scientific Diagram
Investigational antiviral drugs for the treatment of COVID-19 patients | SpringerLink
Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
Marine Drugs | Free Full-Text | Antitumor Peptides from Marine Organisms | HTML
Phamamar achieve to extend the comercialization of its marine derived anti cancer drugs over eleven latinamerican countries.
Establishment and characterisation of a human carcinoma cell line with acquired resistance to Aplidin™ | British Journal of Cancer
Plitidepsin mechanism of action. | Download Scientific Diagram
Frontiers | Beyond Vaccines: Clinical Status of Prospective COVID-19 Therapeutics | Immunology
Of 72 antivirals tested in the laboratory, plitidepsin proves to be the most effective in preventing SARS-CoV-2 replication | IrsiCaixa
Aplidin, plitidepsin, as PM90001 | PharmaMar
Aplidin® induces JNK-dependent apoptosis in human breast cancer cells via alteration of glutathione homeostasis, Rac1 GTPase activation, and MKP-1 phosphatase downregulation | Cell Death & Differentiation
